A Metal–Polyphenol‐Based Antidepressant for Alleviating Colitis‐Associated Mental Disorders
Advanced Materials · 2025-01 · 37 (3)
DOI: 10.1002/adma.202410993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 02.12.2024. Verfasst von Zihao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical En…. Hauptthemen laut MEDLINE: Antidepressive Agents, Colitis, Polyphenols, Mental Disorders. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Open Research Fund of Southeast University and Jiangsu Province Hospital.
Abstract (Originalsprache)
Emerging evidence suggests that patients with inflammatory bowel diseases (IBDs) are predisposed to psychosocial disturbances, such as depression and anxiety. Regrettably, clinical antidepressants exhibit unsatisfactory therapeutic efficacy in IBD‐associated psychosocial disturbances, primarily attributed to the inherent intestinal disorders and intricate bidirectional relationship between the gut and the brain. Herein, we report a metal–polyphenol‐based antidepressant to alleviate mental disorders in dextran sulfate sodium‐induced experimental acute colitis mice via modulating the microbiota–gut–brain axis. The antidepressant, termed CSMTC, comprises a core of melittin‐encapsulated natural antioxidant enzymes (i.e., catalase and superoxide dismutase) and a protective shell composed of tannic acid–cerium ion network. Upon oral administration to colitis mice, CSMTC can effectively restore colonic redox balance, reinforce the intestinal barrier, modulate gut microbiota composition, maintain the blood–brain barrier integrity, and regulate systemic immune responses. Notably, behavioral test results reveal that CSMTC significantly alleviates the colitis‐associated mental disorder (e.g., depression‐like behavior) via the microbiota–gut–brain axis by reducing neuroinflammation, enhancing hippocampal neural plasticity, modulating hippocampal immune responses, and restoring neurotransmitter homeostasis. This work may have implications for the development of new nanodrugs for treating inflammation‐associated complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, Jiangsu Key Laboratory for Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 211189, P. R. China.
- International Innovation Center for Forest Chemicals and Materials and Jiangsu Co-Innovation Center for Efficient Processing and Utilization of Forest Resources, Nanjing Forestry University, Nanjing, 211189, P. R. China.
- Department of Obstetrics and Gynaecology, Zhongda Hospital, Southeast University, Nanjing, 210009, P. R. China.
ORCID-Profile: Fu-Gen Wu
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Open Research Fund of Southeast University and Jiangsu Province Hospital
- SEU Innovation Capability Enhancement Plan for Doctoral Students
Zitieren
APA
Wang, Z., Wang, Z. X., Xu, K. F., An, Y., Cui, M., Zhang, X., Tian, L., Li, C., & Wu, F. G. (2025). A Metal–Polyphenol‐Based Antidepressant for Alleviating Colitis‐Associated Mental Disorders. Advanced Materials, 37(3). https://doi.org/10.1002/adma.202410993
Vancouver
Wang Z, Wang ZX, Xu KF, An Y, Cui M, Zhang X, et al. A Metal–Polyphenol‐Based Antidepressant for Alleviating Colitis‐Associated Mental Disorders. Advanced Materials. 2025;37(3). doi:10.1002/adma.202410993
BibTeX
@article{Wang2025,
author = {Wang, Zihao and Wang, Zi-Xi and Xu, Ke-Fei and An, Yaolong and Cui, Macheng and Zhang, Xinping and Tian, Linan and Li, Chengcheng and Wu, Fu-Gen},
title = {A Metal–Polyphenol‐Based Antidepressant for Alleviating Colitis‐Associated Mental Disorders},
journal = {Advanced Materials},
year = {2025},
volume = {37},
number = {3},
doi = {10.1002/adma.202410993}
}
EUVIMED